Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Assets Average (2016 - 2025)

Historic Assets Average for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $1.6 billion.

  • Collegium Pharmaceutical's Assets Average rose 1902.21% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 1902.21%. This contributed to the annual value of $1.4 billion for FY2024, which is 2112.07% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Assets Average stood at $1.6 billion for Q3 2025, which was up 1902.21% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Assets Average registered a high of $1.6 billion during Q4 2024, and its lowest value of $645.0 million during Q1 2021.
  • Over the past 5 years, Collegium Pharmaceutical's median Assets Average value was $1.2 billion (recorded in 2023), while the average stood at $1.2 billion.
  • Its Assets Average has fluctuated over the past 5 years, first soared by 8324.13% in 2022, then tumbled by 1073.11% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Assets Average (Quarter) stood at $716.9 million in 2021, then skyrocketed by 65.64% to $1.2 billion in 2022, then fell by 2.28% to $1.2 billion in 2023, then skyrocketed by 42.13% to $1.6 billion in 2024, then dropped by 2.99% to $1.6 billion in 2025.
  • Its Assets Average stands at $1.6 billion for Q3 2025, versus $1.6 billion for Q2 2025 and $1.6 billion for Q1 2025.